Tata Chemicals Ltd (TATACHEM) is currently trading at 607.25 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Tata Chemicals is a science-led sustainable chemistry company producing soda ash, sodium bicarbonate, salt, silica, specialty products, and agricultural inputs through Rallis India. It operates across India, the United States, the United Kingdom, Kenya, Singapore, and Morocco-linked operations, combining basic chemistry scale with specialty and farming-essential businesses. The quarter showed a sharp divergence between standalone and consolidated performance. Standalone EBITDA rose 22% year-on-year to ₹292 crore, while consolidated EBITDA fell 29% to ₹381 crore because overseas operations faced lower US realisations, higher energy and logistics costs, Kenya’s temporary suspension, and geopolitical disruptions. Tata Chemicals’ portfolio is undergoing a deliberate shift toward stable, non-cyclical, application-led businesses. Capacity additions in vacuum salt, precipitated silica, bicarbonate, and specialty products, together with the Novabay acquisition, indicate an attempt to reduce dependence on soda ash cycles while improving product mix and downstream value capture. H1FY27 revenue increased 11% to ₹8,432 crore, but EBITDA declined 21% to ₹936 crore and PAT fell to ₹10 crore. The central issue is not demand alone: volume growth was positive, yet lower realisations, input inflation, fixed-cost escalation, depreciation, and weak overseas profitability materially diluted operating leverage. The company maintains substantial innovation and sustainability infrastructure, including 479 patents filed and 184 granted, a Global Capability Centre, IIoT initiatives, biomass and heat-recovery projects, carbon-capture experience, biodiversity programmes, and multiple R&D centres. These capabilities support longer-term differentiation, though near-term earnings remain exposed to global chemical cycles.

Over the past 52 weeks, Tata Chemicals Ltd has traded between a low of ₹570.10 and a high of ₹862.90. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Tata Chemicals Ltd has a market capitalization of approximately 15,470.30. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Tata Chemicals Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -7.85 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 15,470.30 Cr, Tata Chemicals Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Tata Chemicals Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Tata Chemicals Ltd is -7.85. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Tata Chemicals Industrial Essentials reported a Rs 190 crore EBIT loss in H1FY27 after a Rs 147 crore EBIT profit in H1FY26. The presentation cited lower US realisations, higher input and fixed costs, UK energy and logistics pressure, and Kenya’s temporary suspension.

Tata Chemicals’ consolidated profit after tax fell to ₹10 crore from ₹535 crore as EBITDA declined to ₹936 crore from ₹1,186 crore. Management cited lower realisations and higher input and fixed costs, while the H1 EBITDA bridge showed a ₹237 crore adverse price effect and a ₹205 crore fixed-cost effect.

Tata Chemicals reported a Rs 50 crore consolidated loss because total expenses of Rs 4,298 crore exceeded total income of Rs 4,272 crore. Industrial Essentials recorded a Rs 120 crore segment loss, while operating margin declined to 0.72% from 6.50% a year earlier.

Tata Chemicals is scheduled to consider and approve Q2 FY27 results on 7 November 2026. The board meeting will also consider the financial results for the half-year ended 30 September 2026.